Search
Advanced Search

034987/2024 Sansil074-2024 Doxorubicina Cloroidrato (Cig: B2D31Ead30)

ca

General Information
   Oct 9, 2024
   Italian
   Other
955 EUR
   published: Oct 9, 2024

Original Text

SANSIL074-2024 Doxorubicina cloroidrato Esito



Importo a base di gara (comprensivo di costi di sicurezza e ulteriori componenti non ribassabili):
€ 955,00
Costi di sicurezza non ribassabili:
€ 0,00
Importo subappaltabile a terzi:
0 %
CIG/SMART CIG:
B2D31EAD30
Cup:
E53C23001830005
Esito:
Aggiudicato
Stazione appaltante:
SCUOLA NORMALE SUPERIORE DI PISA - Struttura...
Subscription Options

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact Us

Contract award information
   Merck Life Science S.r.l.
   Merck Life Science S.r.l. VIA MONTE ROSA, 93 - 20149 Milano (MI), Italia P.IVA -13209130155, C.F. 13209130155
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any suggestions for updates/corrections for this notice, please let us know.